retroperitoneal sarcoma (Cancer)
Information
- Disease name
- retroperitoneal sarcoma
- Disease ID
- DOID:12341
- Description
- "A malignant retroperitoneal cancer and sarcoma that is located_in the retroperitoneal space." [url:http\://en.wikipedia.org/wiki/Retroperitoneal_space, url:http\://www.ncbi.nlm.nih.gov/pmc/articles/PMC1665230/]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT04224948 | Active, not recruiting | N/A | The PET- Retroperitoneal Sarcoma Study | January 3, 2020 | December 31, 2024 |
NCT04189783 | Active, not recruiting | Phase 2 | Repeat or Single Quadratus Lumborum Block for the Reduction of Opioid Prescriptions After Surgery in Retroperitoneal Sarcoma Patients ("RESQU-SARC" Trial) | June 8, 2020 | December 31, 2024 |
NCT03792867 | Active, not recruiting | N/A | Radical Resection and HIPEC for Recurrent Retroperitoneal Sarcoma | July 23, 2018 | March 31, 2024 |
NCT04225494 | Completed | Perioperative Residual Adrenal Function After Extended Resection for Retroperitoneal Soft Tissue Sarcomas | June 1, 2019 | May 21, 2021 | |
NCT03877588 | Completed | N/A | Nutritional Status in Retroperitoneal Sarcoma. | December 6, 2016 | November 30, 2018 |
NCT05044624 | Completed | N/A | Retroperıtoneal Soft-Tıssue Sarcomas | March 1, 2016 | June 1, 2021 |
NCT02384473 | Completed | Early Phase 1 | Real-Time Contrast-Enhanced Ultrasonography and Shear Wave Elastography in Predicting Treatment Response in Patients With Soft Tissue Sarcoma | December 24, 2014 | January 19, 2024 |
NCT05844813 | Enrolling by invitation | Phase 4 | Neoadjuvant Chemotherapy Combined With Targeted Treatment in High-risk Retroperitoneal Sarcoma | November 1, 2022 | November 1, 2027 |
NCT06025747 | Not yet recruiting | Phase 1 | Evaluation of Abemaciclib and Radiation Therapy Before Surgery for the Treatment of High-Risk Adipocytic Retroperitoneal Sarcoma | July 1, 2024 | March 3, 2026 |
NCT06327477 | Recruiting | Phase 1/Phase 2 | Proton-Spatially Fractionated Radiotherapy and Standard Radiation Therapy for the Treatment of Newly Diagnosed Retroperitoneal Soft Tissue Sarcoma | April 2, 2024 | July 1, 2028 |
NCT01659203 | Recruiting | Phase 1/Phase 2 | Proton or Photon RT for Retroperitoneal Sarcomas | December 2012 | August 2025 |
NCT03838718 | Recruiting | REtroperitoneal SArcoma Registry: an International Prospective Initiative | September 1, 2016 | December 31, 2030 | |
NCT04031677 | Recruiting | Phase 3 | Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma | January 20, 2021 | April 21, 2028 |
NCT05224934 | Recruiting | Phase 2 | Preoperative Ultra-hypofractionated Radiotherapy Followed by Surgery for Retroperitoneal Sarcoma | January 1, 2022 | December 31, 2024 |
NCT05631379 | Recruiting | Influence of Nutritional Status on Oncologic and Operative Outcome in Patients Operated for Retroperitoneal Sarcoma | December 2, 2022 | December 2023 | |
NCT00901836 | Terminated | N/A | Preoperative Proton Radiotherapy for Retroperitoneal Sarcoma | May 2009 | November 2012 |
NCT05302570 | Withdrawn | Phase 2 | Neoadjuvant Short-course Hypofractionated PBT for Non-metastatic RPS | December 2022 | December 2027 |
- Disase is a (Disease Ontology)
- DOID:5875
- Cross Reference ID (Disease Ontology)
- NCI:C4832
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:307219002
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0585129